Erin Mullane

Patient-Reported Neuropsychiatric Outcomes of Long-Term Survivors after Chimeric Antigen Receptor T Cell Therapy

Julia Ruark, Erin Mullane, Nancy Cleary et al. · Biology of Blood and Marrow Transplantation · 2019 · 171 citations · Full text

Life Sciences, Immunology, Oncology +13

Severe cytokine release syndrome is associated with hematologic toxicity following CD19 CAR T-cell therapy

Krishna R. Juluri, Qian Wu, Jenna Voutsinas et al. · Blood Advances · 2021 · 145 citations · Full text

Life Sciences, Hematology, Immunology +17

Phase I study of immunotherapy for advanced ROR1+ malignancies with autologous ROR1-specific chimeric antigen receptor-modified (CAR)-T cells.

Jennifer M. Specht, Sylvia Lee, Cameron J. Turtle et al. · Journal of Clinical Oncology · 2018 · 33 citations

Life Sciences, Immunology, Oncology +17

Abstract P2-09-13: A phase I study of adoptive immunotherapy for ROR1+ advanced triple negative breast cancer (TNBC) with defined subsets of autologous T cells expressing a ROR1-specific chimeric antigen receptor (ROR1-CAR)

JM Specht, Cameron J. Turtle, Christoph Berger et al. · Cancer Research · 2019 · 28 citations

Medicine, Immunology, Oncology +17

Outcomes of Patients with Large B-Cell Lymphomas and Progressive Disease Following CD19-Specific CAR T-Cell Therapy

Victor A. Chow, Ajay K. Gopal, David G. Maloney et al. · Blood · 2018 · 26 citations

Medicine, Hematology, Immunology +12